An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy
NCT00861042
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class
Conditions
Painful Diabetic Neuropathy
Interventions
DRUG:
SPM927/Lacosamide
Sponsor
UCB Pharma